Document Detail


Helicobacter pylori-positive duodenal ulcer: a long-term double-blind randomized study in patients healed with H2-receptor antagonists.
MedLine Citation:
PMID:  9398896     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The NIH Consensus Conference in 1994 (1) concluded that all patients with peptic ulcer disease should be tested and treated for Helicobacter pylori and that further evaluation was needed for patients in remission. MATERIALS AND METHODS: We evaluated in a double blind randomization 30 patients whose duodenal ulcers had been healed with H2-receptor antagonists and who remained in remission on maintenance therapy. After ulcer healing and the presence of H. pylori had been confirmed, these patients were randomized to receive eradication therapy or placebo and were followed for a mean period of 23 months. RESULTS: Almost all patients receiving placebo had ulcer recurrence, whereas the patients treated with antibiotics demonstrate a low recurrence rate. CONCLUSION: These data suggest, for the first time to our knowledge, the importance of treating with antibiotics duodenal ulcer patients whose disease is in remission.
Authors:
R Suriani; M Ravizza; C Pallante; D Mazzucco; E Cardesi; M Colozza; M Malandrino; R Oneglio; G Orso Giacone; P Dusio; M Vajo
Related Documents :
3994436 - Transthoracic vagotomy for postoperative peptic ulcer. effects on basal, sham feeding- ...
15210456 - Ultrasound-guided injection of polidocanol microfoam in the management of venous leg ul...
3303296 - Medical and surgical prophylaxis for duodenal ulcer, the role of sucralfate.
375436 - Healing of peptic ulcers on conventional antacid therapy with or without butriptyline.
12482166 - Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of differ...
21172486 - Transapical versus transfemoral aortic valve implantation: a comparison of survival and...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Helicobacter     Volume:  1     ISSN:  1083-4389     ISO Abbreviation:  Helicobacter     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1998-01-14     Completed Date:  1998-01-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9605411     Medline TA:  Helicobacter     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  151-4     Citation Subset:  IM    
Affiliation:
Servizio di Endoscopia e di Microbiologia Ospedale di Rivoli, Torino, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antacids / administration & dosage,  therapeutic use*
Anti-Ulcer Agents / therapeutic use*
Disease-Free Survival
Double-Blind Method
Doxycycline / administration & dosage,  therapeutic use*
Drug Therapy, Combination / administration & dosage,  therapeutic use*
Duodenal Ulcer / drug therapy*,  etiology,  microbiology,  prevention & control
Female
Gastritis / complications*,  drug therapy
Helicobacter Infections / complications*,  drug therapy
Helicobacter pylori*
Histamine H2 Antagonists / therapeutic use*
Humans
Life Tables
Male
Metronidazole / administration & dosage,  therapeutic use*
Middle Aged
Organometallic Compounds / administration & dosage,  therapeutic use*
Ranitidine / therapeutic use*
Recurrence
Remission Induction
Chemical
Reg. No./Substance:
0/Antacids; 0/Anti-Ulcer Agents; 0/Histamine H2 Antagonists; 0/Organometallic Compounds; 443-48-1/Metronidazole; 564-25-0/Doxycycline; 57644-54-9/bismuth tripotassium dicitrate; 66357-35-5/Ranitidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter...
Next Document:  Effect of omeprazole therapy on the survival of Helicobacter pylori, urease activity, and antral gas...